Showing all news

MRC Technology welcomes launch of Knowledge Quarter

MRC Technology is a member of the newly launched Knowledge Quarter, set up to create a vibrant knowledge hub by bringing together organisations that are actively involved in the advancement and dissemination of knowledge.

4 December 2014

MRC Technology and Shandong International Biotechnology Park (China) to cooperate in new drug for Alzheimer’s

MRC Technology and Shandong International Biotechnology Park (BIOasis) have signed a partnership agreement for the development of a new Alzheimer’s drug. Signed by Fu Fenghua, General Manager of BIOasis and Michael Dalrymple, Director of Business Development at MRC Technology, the development of a new drug for Alzheimer’s could be significant to over 35 million people currently affected by the disease. Financial terms have not been disclosed.

2 December 2014

Poster presented at ELRIG 2014

Khurana, P., Levy, A., Kamal, A., Mordue, R., Newman, M., Osborne, S., Saxty, B., Ganley, I., Wright, P.D., (2014).  A fluorescence based high throughput assay to identify inhibitors of the autophagy associated kinase ULK1. In: Drug Discovery ’14, 2-3 September 2014, Manchester, UK

17 November 2014

Catherine Kettleborough elected to SLAS Europe Council

Congratulations to Catherine Kettleborough, MRC Technology’s Associate Director of Drug Discovery Biology, who has been elected to the SLAS Europe Council for three years starting January 2015!

10 November 2014
Showing all news